Use of secondary prevention medications among adults with reduced kidney function

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 4, 2012, Pages 604-611

  Chang, Tara I ^a   Gao, Liyan ^b   Brown, Todd M ^c   Safford, Monika M ^c   Judd, Suzanne E ^d   McClellan, William M ^e,f   Limdi, Nita A ^d,g   Muntner, Paul ^b,d   Winkelmayer, Wolfgang C ^a  

^a STANFORD UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY   (United States)

^g University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PILL; RATING SCALE; REGRESSION ANALYSIS; SECONDARY PREVENTION; STROKE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84859527221     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11441111     Document Type: Article

References (32)

1. National Kidney Foundation: KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease, 2002. Available at http://www.kidney.org/professionals/ KDOQI/guidelines_bp/index.htm. Accessed May 25, 2010
2. McClellan WM, Langston RD, Presley R: Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. J Am Soc Nephrol 15: 1912-1919, 2004
3. Bang H, Mazumdar M, Newman G, Bomback AS, Ballantyne CM, Jaffe AS, August PA, Kshirsagar AV: Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. Nephrol Dial Transplant 24: 2452-2457, 2009
4. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA; AHA/ ACCNational Heart, Lung, and Blood Institute: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 113: 2363-2372, 2006
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
6. Abbott KC, Bohen EM, Yuan CM, Yeo FE, Sawyers ES, Perkins RM, Lentine KL, Oliver DK, Galey J, Sebastianelli ME, Scally JP, Taylor AJ, Boal TR: Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system. Am J Kidney Dis 47: 593-603, 2006
7. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555-562, 2002
8. Chertow GM, Normand SL, McNeil BJ: Renalism: Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 15: 2462-2468, 2004
9. Fried LF, Lee JS, Shlipak M, Chertow GM, Green C, Ding J, Harris T, Newman AB: Chronic kidney disease and functional limitation in older people: Health, aging and body composition study. J Am Geriatr Soc 54: 750-756, 2006
10. Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ: Prevalence ofmajor depressive episode in CKD. Am J Kidney Dis 54: 424-432, 2009
11. Tsai CF, Wang SJ, Fuh JL: Moderate chronic kidney disease is associated with reduced cognitive performance in midlife women. Kidney Int 78: 605-610, 2010
12. Gehi AK, Ali S, Na B, Whooley MA: Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: The heart and soul study. Arch Intern Med 167: 1798-1803, 2007
13. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS: Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 155: 772-779, 2008
14. Qato DM, Lindau ST, Conti RM, Schumm LP, Alexander GC: Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf 19: 834-842, 2010
15. Charles H, Good CB, Hanusa BH, Chang CC, Whittle J: Racial differences in adherence to cardiac medications. J Natl Med Assoc 95: 17-27, 2003
16. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G: The reasons for geographic and racial differences in stroke study: Objectives and design. Neuroepidemiology 25: 135-143, 2005
17. Morton LM, Cahill J, Hartge P: Reporting participation in epidemiologic studies: A survey of practice. Am J Epidemiol 163: 197-203, 2006
18. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, Shahar E, Kalsbeek W; The Atherosclerosis Risk in Communities (ARIC) Study Investigators: Differences between respondents and nonrespondents in amulticenter community-based study vary by gender ethnicity. J Clin Epidemiol 49: 1441-1446, 1996
19. MESA: Mesa Exam 1 Participation Rate (10/13/2004), 2004. Available at http://www.mesa-nhlbi.org/participation.aspx. Accessed July 5, 2011
20. Radloff LS: The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1: 385-401, 1977
21. Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC: Six-itemscreener to identify cognitive impairment among potential subjects for clinical research. Med Care 40: 771-781, 2002
22. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24: 67-74, 1986
23. Shalansky SJ, Levy AR, Ignaszewski AP: Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 38: 1363-1368, 2004
24. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
25. Abutaleb N: Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components. Nephrol Dial Transplant 22: 2728-2729, 2007
26. Thompson ML, Myers JE, Kriebel D: Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data:What is to be done? Occup Environ Med 55: 272-277, 1998
27. White IR, Royston P, Wood AM: Multiple imputation using chained equations: Issues and guidance for practice. StatMed 30: 377-399, 2011
28. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD; Acute Coronary Treatment and Intervention Outcomes Network registry: Use of evidencebased therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 121: 357-365, 2010
29. Winkelmayer WC, Charytan DM, Brookhart MA, Levin R, Solomon DH, Avorn J: Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol 1: 796-801, 2006
30. Winkelmayer WC, Levin R, Setoguchi S: Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol 3: 1415-1422, 2008
31. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 353: 487-497, 2005
32. Chang TI, Desai M, Solomon DH, Winkelmayer WC: Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol 6: 864-869, 2011